CITIGROUP INC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$262,387
+134.3%
99,767
+276.9%
0.00%
Q4 2022$111,981
+11098.1%
26,473
+4730.8%
0.00%
Q3 2022$1,000
-66.7%
548
-43.9%
0.00%
Q2 2022$3,000
-50.0%
977
-53.1%
0.00%
Q1 2022$6,000
-78.6%
2,084
-77.4%
0.00%
Q4 2021$28,000
-34.9%
9,225
+51.0%
0.00%
Q3 2021$43,000
-94.9%
6,111
-93.4%
0.00%
-100.0%
Q2 2021$846,000
-50.4%
92,153
-47.4%
0.00%0.0%
Q1 2021$1,704,000
+18.2%
175,252
+24.7%
0.00%
Q4 2020$1,442,000
+13.5%
140,558
+11.7%
0.00%
Q3 2020$1,270,000
-49.4%
125,874
-47.7%
0.00%
-100.0%
Q2 2020$2,508,000
+0.4%
240,544
-18.8%
0.00%0.0%
Q1 2020$2,499,000
-38.6%
296,244
-36.3%
0.00%
-33.3%
Q4 2019$4,072,000
-9.4%
465,329
+11.5%
0.00%
-25.0%
Q3 2019$4,493,000
-18.2%
417,396
-3.4%
0.00%
-20.0%
Q2 2019$5,494,000
+31.2%
432,213
+300.3%
0.01%
+25.0%
Q1 2019$4,189,000
-39.7%
107,960
-68.3%
0.00%
-42.9%
Q4 2018$6,942,000
+174.2%
341,070
+517.7%
0.01%
+250.0%
Q3 2018$2,532,000
-31.3%
55,217
-11.4%
0.00%
-50.0%
Q2 2018$3,684,000
+29.9%
62,295
+49.5%
0.00%
+100.0%
Q1 2018$2,837,000
-72.8%
41,670
-60.6%
0.00%
-75.0%
Q4 2017$10,445,000
+31.4%
105,670
+59.2%
0.01%
+14.3%
Q3 2017$7,947,000
-23.4%
66,365
-44.1%
0.01%
-22.2%
Q2 2017$10,379,000
+240.6%
118,762
+45.0%
0.01%
+350.0%
Q1 2017$3,047,000
-60.6%
81,916
-67.5%
0.00%
-75.0%
Q4 2016$7,727,000
+168.0%
251,674
+485.4%
0.01%
+166.7%
Q3 2016$2,883,000
+897.6%
42,995
+343.7%
0.00%
Q2 2016$289,000
+31.4%
9,691
+29.6%
0.00%
Q1 2016$220,000
-90.3%
7,480
-74.0%
0.00%
-100.0%
Q4 2015$2,257,000
+73.5%
28,783
+66.7%
0.00%
+100.0%
Q3 2015$1,301,000
+154.6%
17,265
+293.2%
0.00%
Q2 2015$511,000
-44.0%
4,391
+13.6%
0.00%
-100.0%
Q1 2015$913,000
-43.2%
3,867
-54.5%
0.00%0.0%
Q4 2014$1,608,000
-80.5%
8,497
-75.5%
0.00%
-85.7%
Q3 2014$8,259,000
+2150.4%
34,620
+521.9%
0.01%
Q2 2014$367,000
-53.6%
5,567
-26.7%
0.00%
-100.0%
Q1 2014$791,000
+2.5%
7,593
+1.8%
0.00%0.0%
Q4 2013$772,000
+1738.1%
7,461
+842.0%
0.00%
Q3 2013$42,0007920.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders